Skip to main content
. Author manuscript; available in PMC: 2020 Dec 1.
Published in final edited form as: AIDS. 2019 Dec 1;33(15):2363–2374. doi: 10.1097/QAD.0000000000002371

Table 2: Summary statistics for biomarkers levels in YWH (n=128).

Values are mean (standard deviation) unless otherwise noted.

Biomarker (n=128)
Macrophage Activation
sCD14 (ng/mL) 1468.04 (420.66)
sCD163 (ng/mL) 548.40 (304.97)
CCL2 (pg/mL) 209.54 (304.35)
GM-CSF (pg/mL) 1.55 (2.42)
 Below Limit of Detection (LOD 0.01 pg/mL)a 53 (41.4%)
IL-1β(pg/mL) 38.15 (116.63)
 Below Limit of Detection (LOD 0.01 pg/mL)a 33 (25.8%)
IL-6 (pg/mL) 17.43 (74.66)
 Below Limit of Detection (LOD 0.1 pg/mL)a 26 (20.3%)
IL-8 (pg/mL) 64.69 (291.50)
LPS (EU/mL) 0.21 (0.08)
MMP-2 (ng/mL) 195.64 (39.29)
TNFα (pg/mL) 11.35 (25.71)
Vascular Inflammation
sICAM-1 (ng/mL) 215.07 (303.69)
sVCAM-1 (ng/mL) 595.20 (238.83)
CRP (ng/mL) 1424.01 (5517.78)
MPO (ng/mL) 279.70 (270.26)
Lymphocyte Activation
sCD27 (U/mL) 57.39 (36.91)
IFNγ (pg/mL) 20.23 (44.42)
 Below Limit of Detection (LOD 0.1 pg/mL)a 49 (38.3%)
IL-10 (pg/mL) 8.25 (14.82)
 Below Limit of Detection (LOD 0.1 pg/mL)a 35 (27.3%)
sIL-2rα (pg/mL) 67.91 (80.67)
 Below Limit of Detection (LOD 0.1 pg/mL)a 1 (0.8%)
a

Frequency (percent)